Dexcom Selected as First Manufacturer in FDA's Innovative Digital Health Outcomes Program

Dexcom has been selected as the first manufacturer to participate in the FDA's Innovative Digital Health Outcomes Program, focusing on supporting CMS's ACCESS model. The initiative aims to improve glycemic control and screen for prediabetes and type 2 diabetes through digital health technology.